N/A
Completed N=20
Tailored to You (TTY) Pilot Study
Source: ClinicalTrials.gov NCT05141175 ↗Enrolled (actual)
20
Serious AEs
0.0%
Results posted
May 2023
Primary outcomePrimary: Number of Participants Enrolled as Measured by Enrollment Logs — 20 Participants
Summary
The purpose of this research study is to use a test called impedance cardiography (ICG) to provide more information about how to improve the control of blood pressure. Participants will be given this test so investigators can get more information about what is going on inside the heart and blood vessels that is contributing to high blood pressure. ICG is a lot like an EKG (electrocardiogram) in that it uses electrodes and a computer to make a report. Participants will lie down on the exam table and two electrodes go on the right ankle and two electrodes go on the left wrist. The process takes about 5 minutes and is painless and not invasive.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Enrolled as Measured by Enrollment Logs |
20 | — |
| PRIMARY Number of Participants That Completed Study as Measured by Enrollment Logs |
19 | — |
| SECONDARY Change in Blood Pressure as Measured by Medical Record |
11; 3 | — |
| SECONDARY Number of Anti-hypertensive Medications Prescribed as Measured by Medical Record Review |
2.60 | — |
Eligibility Criteria
Inclusion Criteria
- Documented diagnosis of hypertension
- Most recent office systolic BP average measured using automated office BP (AOBP) is ≥140 mmHg systolic or ≥90 mmHg diastolic
- Currently prescribed at least one BP-lowering medication
- Under the care of a primary care clinician
Exclusion Criteria
-
Data sourced from ClinicalTrials.gov (NCT05141175). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.